Skip to main content
. 2021 Mar 4;26(9):1900606. doi: 10.2807/1560-7917.ES.2021.26.9.1900606

Table 1. Overview of per-sample costs of whole genome sequencing vs conventional methods, by cost type, case studies covering a specified reference period between 2016 and 2019 (n = 8 institutes).

Case study area Avian influenza (HPAI) Influenza A+B Food-borne pathogensa
Institution APHA (UK) FLI (DE) EMC (NL) IZSLER (IT) INEI-ANLIS (ARG) MDH (US) PHAC (CAN) PHE (UK)
Outbreak or routine surveillance Outbreak Outbreak Routine surveillance Routine surveillance Routine surveillance Routine surveillance Routine surveillance Routine surveillance
Number of samples in reference period 26 30 630 175 320 1,767 8,630 15,791
in 8 months 3 months 5 months 12 months 12 months 12 months 12 months 12 months
WGS
Sequencer used Illumina
MiSeq
IonTorrent
PGM
Nanopore GridION Illumina MiSeq Illumina MiSeq Illumina MiSeq Illumina MiSeq Illumina HiSeq
Batch size for sample processing/sequencing 1–2 6 30 24 12 24 32 Processing: 40
Sequencing: 96
Equipment € 58.53 € 210.71 € 2.50 € 163.49 € 43.02 € 29.53 € 75.90 € 35.23
Consumables € 830.97 € 254.88 € 33.52 € 165.37 € 104.62 € 104.40 € 69.75 € 53.92
Staff costs Professionals € 39.63 € 42.60 € 15.95 € 52.35 € 6.85 € 20.58 € 61.82 € 28.30
Technicians € 87.50 € 60.19 € 42.83 € 13.93 € 0.00 € 0.00 € 7.89 € 7.15
Other costs € 0.00 € 0.00 € 3.68b € 0.00 € 0.00 € 0.00 € 0.00 € 0.00
Total per-sample cost WGS € 1,016.63 € 568.37 € 98.48 € 395.14 € 154.49 € 154.51 € 215.36 € 124.59
Conventional methodsc
Method(s) used Sanger sequencing (HA/NA analysis) Sanger sequencing (whole genomed) PCR; Sanger sequencing (HA/NA); virus isolation; HI; virus neutralisation; NA STAR Serotyping; PFGE; PCR; MLVA Biochemical analysis; serotyping; PCR typing; MaldiTOF; PFGE PFGE; PCR; MaldiTOF PFGE; biochemical testing; serotyping PCR; MLVA; MLST; fAFLP; serotyping; phage typing; PFGE; D-tartrate; glucose gas; AMR; biochemistry
Equipment € 78.55 (€ 137.35)d € 2.66 € 26.04 n.a. € 5.84 € 12.30 € 7.11
Consumables € 21.91 (€ 360.88)d € 34.39 € 20.17 n.a. € 32.89 € 34.95 € 29.91
Staff costs Professionals € 39.63 (€ 230.75)d € 0.38 € 3.52 n.a. € 42.43 € 6.72 € 2.92
Technicians € 150.00 (€ 107.00)d € 45.93 € 25.88 n.a. € 0.00 € 40.32 € 23.85
Other costs € 0.00 (€ 0.00)d € 0.00 € 16.27 n.a. n.a. € 0.00 € 1.67
Total per-sample cost conventional methods € 290.08 (€ 835.98)d € 83.36 € 91.87 € 46.61 € 81.16 € 94.29 € 65.46
Cost difference between WGS and conventional methods
Additional cost WGS € 726.54 (− € 267.61)d € 15.12 € 303.27 € 107.88 € 73.35 € 121.07 € 59.13
Quotient of WGS over conventional methods 3.5 0.7d 1.2 4.3 3.3 1.9 2.3 1.9

AMR: antimicrobial resistance; APHA: Animal and Plant Health Agency; ARG: Argentina; CAN: Canada; DE: Germany; EMC: Erasmus Medical Centre; fAFLP: fluorescent amplified fragment length polymorphism; FLI: Friedrich-Loeffler-Institut; HA: haemagglutinin; HI: haemagglutination inhibition; HPAI: highly pathogenic avian influenza; INEI-ANLIS: Instituto Nacional de Enfermedades Infecciosas - Administración Nacional de Laboratorios e Institutos de Salud; IT: Italy; IZSLER: Istituto Zooprofilattico Sperimentale della Lombardia e dell'Emilia-Romagna; MDH: Maryland Department of Health; MLST: multilocus sequence typing; MLVA: multilocus variable-number tandem repeat analysis; NA: neuraminidase; n.a.: not available; PFGE: pulsed-field gel electrophoresis; PHAC: Public Health Agency Canada; PHE: Public Health England; UK: United Kingdom; US: United States; WGS: whole genome sequencing.

a Salmonella (all), Listeria (IZSLER, PHE, PHAC, MDH), Escherichia coli and Shigella (PHE, INEI-ANLIS, MDH), Campylobacter (PHE, MDH), Vibrio (MDH).

b Costs for supplementary conventional tests that continue to be part of the WGS workflow (virus isolation, HI, virus neutralisation, NA STAR - on a limited number of samples only).

c Note that the cost of conventional methods is a weighted figure which accounts for the use rate of the various methods across the different pathogens.

d Sequencing of a whole genome of a virus using Sanger sequencing – as indicated by FLI as comparator method – is a resource-intensive process that has generally been replaced by next-generation sequencing; Sanger sequencing would typically be used for the (more limited and less resource-intensive) HA/NA analysis (the comparator method used by APHA). The figures from the FLI case study are therefore placed in brackets and are provided for comparison purposes only.